Background: Okinawa mozuku (Cladosiphon okamuranu) is a type of edible seaweed of the family Chordariaceae that typically contains the polysaccharide fucoidan as a functional
containing any dried Okinawa mozuku powder were each made into capsules and given to healthy men and women with infrequent weekly bowel movements (2-4 movements a week) to ingest for eight weeks. We then investigated changes in the defecation situation, blood tests, and adverse events.
Results:
In the group that ingested the capsules containing dried Okinawa mozuku powder, the number of days with a bowel movement significantly increased compared with the placebo group after four weeks of ingestion (p < 0.05). Furthermore, after eight weeks of ingestion, the same increasing trend was seen compared with the placebo group (p = 0.0964). The volume of stool also increased significantly in the dried Okinawa mozuku powder group after eight weeks compared with the placebo group. In terms of blood tests and adverse events, no adverse events occurred that were the result of the test food.
Conclusion:
Ingestion of Okinawa mozuku was found to have a regulatory effect on intestinal function by promoting defecation in healthy individuals with a tendency for constipation. This demonstrated that Okinawa mozuku is a functional food capable of making defecation smoother and increasing the volume of stool.
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BACKGROUND
Okinawa mozuku (Cladosiphon okamuranus Tokida) is classified under the order Chordariales family, Chordariales genus, and cladosiphon. It is an edible seaweed that is native in areas spanning the Yaeyama islands in Okinawa prefecture to Amami-Oshima in Kagoshima prefecture [1] . Some of the reported benefits of Okinawa mozuku include its anticoagulant effects [2] , lowering of LDL cholesterol [3] , anti-HIV-virus activity [4] , improvement of functional gastrointestinal damage [5] , and increasing intestinal vermiculation [6] .
The components involved in these benefits of Okinawa mozuku are believed to be the highmolecular polysaccharides. Among these, fucoidan is particularly well known in addition to the chemical structure of fucose as the constituent sugar, with a side chain of uronic acid and sulfate group [7] .
Constipation is an abdominal symptom that is generally due to lack of fiber. Decreased vermiculation of the intestines makes it difficult to have regular bowel movements. When long periods of constipation continue, the stool loses its water content due to staying in the intestines for too long, which causes it to harden. Furthermore, chronic retention of stool in the intestines causes putrid bacteria to increase in the intestinal flora, thereby reducing the number of lactobacillus. This generates indole, skatole, ammonia, and hydrogen sulfide in the intestines, which causes unpleasant symptoms such as infection of the intestinal tissues and feeling bloated.
Constipation is not only associated with abdominal symptoms but can also cause psychological symptoms [8] [9] [10] . Abdominal bloating lowers appetite and leads to feelings of depression.
Consequently, it is clear that regular bowel movements are essential for maintaining a high quality of life. In order to improve the bowel routine, it is important to increase the amount of fiber intake in order to increase lactobacillus or bifidus in the intestinal flora and to lower the emission of putrefaction gases [11] . For example, fucoidan extracted from the Okinawa mozuku has also been reported to improve constipation. However, these are reports which have been based on the intake of refined fucoidan only. Moreover, this is the first report on improvement of the bowel routine from taking Okinawa mozuku by itself. Therefore, we conducted a placebo-controlled double-blind test to study the bowel movement improvement effects of dried Okinawa mozuku.
METHODS

Study design
This study was conducted as a randomized, double-blind, parallel group study. Thirty individuals participated in the study (15 in the Okinawa mozuku group and 15 in the placebo group). The study participants were all healthy adults with infrequent bowel movements (2-4 movements a week) who met all of the inclusion criteria and none of the exclusion criteria listed in Table 1 . All the participants gave their informed consent to take part in the study. The Western Ethics Committee reviewed and approved the study prior to its implementation. Additionally, the study plan was registered with the UMIN Clinical Trials Registry prior to being conducted. (UMIN000025173) 
Randomization
Individuals with no problem participating in the study were allocated to one of two groups by the stratified block randomization method (stratification factors: number of bowel movements and age). An independent person responsible for allocation not involved in the study created a computer program using a random number table to allocate the participants into one of two groups.
Both the participants and the investigators were blinded to the group allocations.
Placebo and test foods
The test food was in the form of capsules containing Okinawa mozuku. The dose was 2.4 g/day (1.0 g/day of fucoidan). Meanwhile, the placebo food was a capsule containing starch instead of Okinawa mozuku. The two foods had no differences in terms of appearance including color, smell, and size. But there was a difference in salty taste in the capsule. The nutritional components and compositions are presented in Table 2 . 
Bowel movement condition (investigation of defecation)
Throughout the study period, the participants answered questionnaires on fecal properties, including the number of bowel movements per day, the number of bowel movements per week, the volume of stool per day (number of medium "egg"-sized stools), and the hardness of stool each day (hard to watery). The questionnaires were tabulated every four weeks.
Blood analysis and adverse events
Hematological and blood biochemical tests were completed before the start of ingestion, after four weeks of ingestion, and after eight weeks of ingestion. Participants were also interviewed about adverse events at each hospital visit to investigate causal relationships and severity.
Statistical analysis
The Mann-Whitney U test and Wilcoxon signed-rank test were performed to examine the number of days with a bowel movement, the number of bowel movements, the hardness of stool, and the volume of stool. The level of statistical significance was set at 5% and a p-value of ≥ 5% to <10%
was considered to indicate a difference in trend. Blood tests were compared between groups by using Student's t-tests. Adverse events were examined using Fisher's exact test. Statistical analyses were done at Kansai University of Welfare Sciences using the software SAS ver. 9.4.
RESULTS
Analysis set
The study included a total of 30 participants, with 15 subjects in each group. No participants dropped out half way through the study or discontinued the study. The analysis set for efficacy and safety therefore included all the participants. Table 3 shows the profile of subjects who participated in the study 
Bowel movement condition
The results of the study are presented in Table 4 . The number of bowel movements per day rose significantly in both groups compared with before ingestion, although no difference was seen between the groups. Meanwhile, the number of days with a bowel movement per week increased significantly in the Okinawa mozuku group compared with the placebo group after four weeks of ingesting the test food (p = 0.0438). After eight weeks of ingestion, the Okinawa mozuku group showed a significantly increasing trend compared with the placebo group (p = 0.0964). The volume of stool per day also increased significantly in the Okinawa mozuku group compared with the placebo group. After eight weeks of ingestion the hardness of stool had significantly softened compared with before ingestion, but did not differ between the two groups. Table 4 . Fecal Properties: Before, 4-week and 8-week
Blood Analysis and Adverse Events
No changes that could be medically problematic were observed in the blood test results of either group (data not shown). Moreover, while mild adverse events such as bloating occurred, these did not differ significantly between the groups.
DISCUSSION
We had subjects take 2.4 g（fucoidan:1.0ｇ) of Okinawa mozuku to examine its effects on improving bowel movements. We found that four weeks of taking this preparation resulted in significantly increased bowel movement frequency compared to the control group. In past research, Tomori et al [12] reported that taking fucoidan extracted from Okinawa mozuku at 0.5 g/day improved the bowel habits of somewhat constipated healthy individuals. We also found in our study that taking the powder of dried mozuku by itself had the same effects on improving bowel habits. Improvements in gastrointestinal symptoms were reported in past research by Miyoshi et al. [6] , who found that taking fucoidan extracted from Okinawa mozuku 810 mg/day for 4 weeks promoted vermiculation of the intestines. In all past reported cases, refined fucoidan from Okinawa mozuku was taken, and the fucoidan amount was between 0.5g -0.81ｇ. We demonstrated that taking dried mozuku by itself had the same effects on improving bowel movements as taking refined fucoidan. The results of this trial showed that taking Okinawa mozuku directly also regulated intestinal function. Thus, as past reports on improvements in bowel movements from taking refined fucoidan in Okinawa mozuku resulted in almost the same result of improvement, we believe that the fucoidan contained in Okinawa mozuku is the functional component that regulates bowel activity. These mechanisms are not clear, but Ihara reported that fucoidan enhanced intestinal epithelial barrier function by upregulating the expression of claudin-1 [13] . As a result, we think that fucoidan may be an appropriate therapy for the treatment of inflammatory bowel diseases.
CONCLUSION
We conducted a randomized, double-blind, parallel group study using capsules containing dried Okinawa mozuku powder. We found that in the Okinawa mozuku group, the number of days with a bowel movement per week increased and the volume of stool per day significantly increased compared with the placebo group. The aforementioned results demonstrate that Okinawa mozuku is a functional food with a regulatory effect on intestinal function.
